NASDAQ$COO
The Cooper Companies Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
CooperCompanies reported an increase in revenue and earnings for the fourth quarter of 2021.
CooperCompanies announced strong Q4 and full-year 2021 results, with Q4 revenue up 11% year-over-year to $759.1 million and GAAP EPS up 35% to $2.21. The company achieved record annual revenue, profits, and cash flow, driven by market share gains in contact lenses and fertility.
- Fourth quarter revenue increased 11% year-over-year to $759.1 million.
- Fourth quarter GAAP diluted earnings per share (EPS) $2.21, up 35% from last year's fourth quarter.
- Fourth quarter Non-GAAP diluted EPS $3.28, up 4% from last year's fourth quarter.
- Gross margin 66% compared with 62% in last year’s fourth quarter.
Headline financials
Revenue & EPS history
Cooper · Revenue · Quarterly
$759M
Revenue by segment
Cooper · $194M total across 2 segments · Q4 2021
- Office and Surgical$113M+3.3%58.0%
- Fertility$81.6M+23.3%42.0%
Forward guidance
CooperCompanies provided fiscal year 2022 guidance, with total revenue expected to be between $3,032 and $3,090 million and non-GAAP diluted earnings per share between $13.60 and $14.00. This guidance does not include the Generate Life Sciences acquisition.
Tailwinds
- Fiscal 2022 total revenue $3,032 - $3,090 million (up 6% to 8% in constant currency)
- CVI revenue $2,225 - $2,267 million (up 6% to 8% in constant currency)
- CSI revenue $807 - $823 million (up 6% to 8% in constant currency)
- Fiscal 2022 non-GAAP diluted earnings per share $13.60 - $14.00 (up 9.5% to 12.5% in constant currency)
- Company is well positioned to continue executing on our growth strategies across both businesses
Headwinds
- Our fiscal year 2022 guidance does not include the Generate Life Sciences acquisition announced on November 10th, 2021.
- Excludes amortization and impairment of intangible assets, and other exceptional or unusual income or gains and charges or expenses including acquisition, integration and manufacturing related costs which we may incur as part of our continuing operations.
- The company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses.
- Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, the Company is not able to provide such guidance.
- Resurgences as a significant risk factor to our outlook
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+0.5%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.1%
Avg return
30 days after
51%
35 / 68 earnings
Positive
+12.1%
Q3 2024
Best reaction
-12.8%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.6% | -8.0% | -12.5% | |
| Q4 2025 | -4.3% | +4.8% | +5.3% | |
| Q3 2025 | -12.8% | -11.8% | -8.9% | |
| Q2 2025 | +0.0% | -0.3% | +3.6% | |
| Q1 2025 | -6.6% | -13.1% | -18.9% | |
| Q4 2024 | -6.0% | -5.6% | -12.6% | |
| Q3 2024 | +12.1% | +12.1% | +16.4% | |
| Q2 2024 | +3.5% | +3.8% | -4.2% | |
| Q1 2024 | +8.1% | +7.3% | +7.4% | |
| Q4 2023 | -2.2% | -0.7% | +6.8% | |
| Q3 2023 | -2.1% | -3.5% | -15.9% | |
| Q2 2023 | -4.0% | -5.1% | +3.2% | |
| Q1 2023 | +8.7% | +3.9% | +15.4% | |
| Q4 2022 | -1.6% | +4.8% | +9.7% | |
| Q3 2022 | +4.1% | +2.5% | -8.5% | |
| Q2 2022 | -0.3% | +1.3% | -7.2% | |
| Q1 2022 | +2.1% | -8.5% | +3.1% | |
| Q4 2021 | +4.8% | +8.7% | +12.2% | |
| Q3 2021 | +1.1% | -0.7% | -7.6% | |
| Q2 2021 | -0.7% | -3.2% | +6.0% | |
| Q1 2021 | +1.8% | +0.3% | +1.1% | |
| Q4 2020 | +3.3% | +3.3% | +8.6% | |
| Q3 2020 | +2.0% | +0.3% | +5.7% | |
| Q2 2020 | -0.2% | -5.0% | -9.1% | |
| Q1 2020 | -1.3% | -0.9% | -17.3% | |
| Q4 2019 | -1.6% | -2.4% | +3.3% | |
| Q3 2019 | -3.5% | -6.7% | -8.3% | |
| Q2 2019 | +4.5% | +9.0% | +18.2% | |
| Q1 2019 | -1.8% | +0.1% | +1.0% | |
| Q4 2018 | -11.6% | -7.3% | -10.4% | |
| Q3 2018 | -3.7% | -3.4% | +4.3% | |
| Q2 2018 | +1.4% | -0.4% | +6.0% | |
| Q1 2018 | +2.1% | -3.8% | -11.5% | |
| Q4 2017 | -3.2% | -1.9% | -1.5% | |
| Q3 2017 | -4.0% | -2.5% | -3.7% | |
| Q2 2017 | +8.9% | +10.5% | +9.4% | |
| Q1 2017 | -3.1% | -3.6% | -0.4% | |
| Q4 2016 | +1.3% | +4.1% | +5.2% | |
| Q3 2016 | +0.0% | +1.3% | -3.6% | |
| Q2 2016 | -0.1% | -0.4% | +7.1% | |
| Q1 2016 | +6.4% | — | — | |
| Q4 2015 | -12.8% | — | — | |
| Q3 2015 | -7.1% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | +9.7% | — | — | |
| Q4 2014 | -4.4% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.7% | — | — | |
| Q1 2014 | +4.3% | — | — | |
| Q4 2013 | -4.6% | — | — | |
| Q3 2013 | -1.8% | — | — | |
| Q2 2013 | +8.1% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.3% | — | — | |
| Q2 2012 | -4.1% | — | — | |
| Q1 2012 | +2.8% | — | — | |
| Q4 2008 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q2 2011 | +1.4% | — | — | |
| Q2 2010 | +1.4% | — | — | |
| Q1 2010 | +8.9% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q3 2010 | +5.8% | — | — | |
| Q3 2009 | +5.8% | — | — | |
| Q4 2009 | +5.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro